tiprankstipranks
Jounce Therapeutics (JNCE)
NASDAQ:JNCE

Jounce Therapeutics (JNCE) Stock Investors

0 Followers
Based on 666,129 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

- of all portfolios hold JNCE
On average, investors allocate 0.00% of their portfolios to JNCE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently there is not enough data
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding JNCE

-
Last 7
Days
-
Last 30
Days
Percentages indicate the change in the number of portfolios holding JNCE, out of 666,129 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

JNCE Investor Activity

No data currently available
Based on the activity of 12,462 investors who made their portfolios public
The table shows changes in JNCE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

JNCE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.46%
+0.23%
+1.36%
46.26B
Healthcare
Syros Pharmaceuticals
3.75%
-1.72%
-6.07%
68.99M
Healthcare
Blink Charging Co
4.04%
+0.17%
+1.81%
397.42M
Utilities
DraftKings
6.49%
+1.19%
+1.83%
26.12B
Technology
Nikola
5.90%
+1.71%
+3.14%
1.61B
Energy
Twilio
3.15%
-0.53%
-1.10%
12.30B
Technology
Merck & Company
4.63%
-0.48%
-0.56%
272.37B
Healthcare
Applied Materials
4.64%
-0.26%
-0.15%
119.87B
Technology
General Electric
5.61%
+0.13%
-0.13%
120.09B
Industrials
Enphase Energy
5.13%
+1.55%
+6.11%
24.39B
Energy
Based on the activity of 666,129 active portfolios
Open your Smart Portfolio

JNCE Investor Analysis

JNCE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
8.1%
of JNCE holders
are under 35
Average Segment Performance
Average P/E Ratio37.22
Beta10.64
Dividend Yield4.21%
JNCE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
78.4%
of JNCE holders
are between 35–55
Average Segment Performance
Average P/E Ratio39.24
Beta14.53
Dividend Yield4.44%
JNCE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
13.5%
of JNCE holders
are over 55
Average Segment Performance
Average P/E Ratio38.19
Beta5.32
Dividend Yield4.48%
Overview of age group and performance of JNCE stock investors
See who invests in JNCE according to age group and performance.

FAQ

How many retail Investors hold JNCE?
Currently, no data Available
What is JNCE Investor Sentiment?
Currently, no data Available
What percentage of retail investors changed their holding of JNCE in the last 7 days?
Currently, no data Available
What percentage of retail investors changed their holding of JNCE in the last 30 days?
Currently, no data Available
What is the average age of retail investors who hold JNCE?
The average age of JNCE Holders is between 35–55.
    What other stocks have JNCE investors also bought?
    JNCE Investors also bought MRNA, SYRS, BLNK, DKNG, NKLA, TWLO, MRK, AMAT, GE, ENPH.
      Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
      ACADACADIA Pharmaceuticals
      ATECAlphatec Holdings
      AZNAstraZeneca
      CRLCharles River Labs
      CHRSCoherus Biosciences
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis